- Latest week
- 10 Jul 2026
- Close
- 9.480000
- Fair value
- 20.660950
- Next-week expectancy
- Negative 43.46%
SCLX Chart Pack
Scilex Holding Company
Chart Summary
Over the latest 12 completed weeks ending 2026-07-10, SCLX rose 127.58%, moving from 4.17 to 9.48. The latest weekly close is above the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -2.56 and has improved across the 12-week window. Market Dynamics is 1.40 on the latest week. Next-week expectancy is negative at 43.46% based on similar historical setup states.
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 9.48
- 12-Week Change
- 127.58%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Negative 43.46%
- Signal Weeks
- 0 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Below
- Relative Strength
- -2.56
- Market Dynamics
- 1.40
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 9.48
- 12-Week Change
- 127.58%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Negative 43.46%
- Signal Weeks
- 0 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Below
- Relative Strength
- -2.56
- Market Dynamics
- 1.40
Over the latest 12 completed weeks ending 2026-07-10, SCLX rose 127.58%, moving from 4.17 to 9.48. The latest weekly close is above the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -2.56 and has improved across the 12-week window. Market Dynamics is 1.40 on the latest week. Next-week expectancy is negative at 43.46% based on similar historical setup states.
Industry Peers
United States equities in Drug Manufacturers - General
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| GRFS Grifols SA ADR | NASDAQ | 10 Jul 2026 | 7.14 | 7.32 | 7.05 | 7.27 | 1.82% |
| NVO Novo Nordisk A/S | NYSE | 10 Jul 2026 | 49.28 | 50.44 | 48.50 | 49.48 | 0.42% |
| SNY Sanofi ADR | NASDAQ | 10 Jul 2026 | 43.37 | 44.11 | 42.43 | 43.50 | 0.30% |
| PFE Pfizer Inc | NYSE | 10 Jul 2026 | 24.16 | 24.41 | 23.62 | 24.17 | 0.06% |
| OGN Organon & Co | NYSE | 10 Jul 2026 | 13.55 | 13.58 | 13.46 | 13.52 | -0.22% |
| BMY Bristol-Myers Squibb Company | NYSE | 10 Jul 2026 | 57.74 | 58.49 | 56.49 | 57.58 | -0.28% |
| JNJ Johnson & Johnson | NYSE | 10 Jul 2026 | 260.23 | 269.43 | 255.52 | 256.98 | -1.25% |
| LLY Eli Lilly and Company | NYSE | 10 Jul 2026 | 1208.00 | 1249.45 | 1178.32 | 1188.58 | -1.61% |
| MIRA MIRA Pharmaceuticals, Inc. Common Stock | NASDAQ | 10 Jul 2026 | 0.94 | 0.99 | 0.90 | 0.92 | -1.65% |
| GSK GlaxoSmithKline PLC ADR | NYSE | 10 Jul 2026 | 53.80 | 54.29 | 52.30 | 52.78 | -1.90% |
| NVS Novartis AG ADR | NYSE | 10 Jul 2026 | 157.32 | 157.93 | 153.63 | 154.05 | -2.08% |
| AMGN Amgen Inc | NASDAQ | 10 Jul 2026 | 371.70 | 375.25 | 359.47 | 363.39 | -2.24% |
| GILD Gilead Sciences Inc | NASDAQ | 10 Jul 2026 | 132.88 | 137.70 | 127.88 | 129.83 | -2.30% |
| MRK Merck & Company Inc | NYSE | 10 Jul 2026 | 129.31 | 130.00 | 122.90 | 123.54 | -4.46% |
| ABBV AbbVie Inc | NYSE | 10 Jul 2026 | 259.92 | 260.92 | 245.05 | 248.08 | -4.56% |
| MDCX Medicus Pharma Ltd. Common Stock | NASDAQ | 10 Jul 2026 | 0.43 | 0.47 | 0.40 | 0.41 | -4.77% |